Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2023 Financial Results and Recent Updates

Go back to  Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2023 Financial Results and Recent Updates

Anebulo Pharmaceuticals, Inc. (ANEB) Misses Q2 EPS by 4c

February 10, 2023 8:39 AM EST

Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB) reported Q2 EPS of ($0.15), $0.04 worse than the analyst estimate of ($0.11).

For earnings history and earnings-related data on Anebulo Pharmaceuticals, Inc. (ANEB) click here.

... More